Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings

H. Syed Iqbal, P. Balakrishnan, Anitha J. Cecelia, Suniti Solomon, N. Kumarasamy, Vidya Madhavan, K. G. Murugavel, Aylur K. Ganesh, Sunil Solomon, Kenneth H. Mayer, Suzanne M. Crowe

Research output: Contribution to journalArticle

Abstract

An inexpensive and technically less-demanding methodology to quantify HIV-1 viral load would be of great value for resource-limited settings, where the nucleic-acid amplification technique (NAAT) is impractical and/or resource-prohibitive. In this study, an HIV-1 reverse-transcriptase enzyme-activity assay (ExaVir Load assay, version 1) was compared with the gold standard RT-PCR assay, Roche HIV-1 Amplicor Monitor, version 1.5. A total of 121 plasma specimens were used for the evaluation. ExaVir Load had a sensitivity of 97 % and a specificity of 71 % in identifying specimens with -1 in the Roche RT-PCR assay as being less than the detection limit of the assay (5500 copies ml-1). The mean difference (95% limits of agreement) between Roche RT-PCR and ExaVir Load was -0.23 (-1.59 to 1.13) log10(copies ml-1) by Bland-Altman analysis. Significant negative correlations were seen between CD4+ T-cell counts and the ExaVir Load assay (r=-0.32, P+ T-cell counts and the Roche RT-PCR (r=-0.38, P

Original languageEnglish (US)
Pages (from-to)1611-1614
Number of pages4
JournalJournal of Medical Microbiology
Volume56
Issue number12
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Enzyme Assays
Viral Load
Nucleic Acids
HIV-1
Polymerase Chain Reaction
Nucleic Acid Amplification Techniques
T-Lymphocytes
Therapeutics
CD4 Lymphocyte Count
Limit of Detection
Cell Count
Human immunodeficiency virus 1 reverse transcriptase

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. / Iqbal, H. Syed; Balakrishnan, P.; Cecelia, Anitha J.; Solomon, Suniti; Kumarasamy, N.; Madhavan, Vidya; Murugavel, K. G.; Ganesh, Aylur K.; Solomon, Sunil; Mayer, Kenneth H.; Crowe, Suzanne M.

In: Journal of Medical Microbiology, Vol. 56, No. 12, 12.2007, p. 1611-1614.

Research output: Contribution to journalArticle

Iqbal, H. Syed ; Balakrishnan, P. ; Cecelia, Anitha J. ; Solomon, Suniti ; Kumarasamy, N. ; Madhavan, Vidya ; Murugavel, K. G. ; Ganesh, Aylur K. ; Solomon, Sunil ; Mayer, Kenneth H. ; Crowe, Suzanne M. / Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. In: Journal of Medical Microbiology. 2007 ; Vol. 56, No. 12. pp. 1611-1614.
@article{822d793107c54e43b9356c4a57224867,
title = "Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings",
abstract = "An inexpensive and technically less-demanding methodology to quantify HIV-1 viral load would be of great value for resource-limited settings, where the nucleic-acid amplification technique (NAAT) is impractical and/or resource-prohibitive. In this study, an HIV-1 reverse-transcriptase enzyme-activity assay (ExaVir Load assay, version 1) was compared with the gold standard RT-PCR assay, Roche HIV-1 Amplicor Monitor, version 1.5. A total of 121 plasma specimens were used for the evaluation. ExaVir Load had a sensitivity of 97 {\%} and a specificity of 71 {\%} in identifying specimens with -1 in the Roche RT-PCR assay as being less than the detection limit of the assay (5500 copies ml-1). The mean difference (95{\%} limits of agreement) between Roche RT-PCR and ExaVir Load was -0.23 (-1.59 to 1.13) log10(copies ml-1) by Bland-Altman analysis. Significant negative correlations were seen between CD4+ T-cell counts and the ExaVir Load assay (r=-0.32, P+ T-cell counts and the Roche RT-PCR (r=-0.38, P",
author = "Iqbal, {H. Syed} and P. Balakrishnan and Cecelia, {Anitha J.} and Suniti Solomon and N. Kumarasamy and Vidya Madhavan and Murugavel, {K. G.} and Ganesh, {Aylur K.} and Sunil Solomon and Mayer, {Kenneth H.} and Crowe, {Suzanne M.}",
year = "2007",
month = "12",
doi = "10.1099/jmm.0.47456-0",
language = "English (US)",
volume = "56",
pages = "1611--1614",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "12",

}

TY - JOUR

T1 - Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings

AU - Iqbal, H. Syed

AU - Balakrishnan, P.

AU - Cecelia, Anitha J.

AU - Solomon, Suniti

AU - Kumarasamy, N.

AU - Madhavan, Vidya

AU - Murugavel, K. G.

AU - Ganesh, Aylur K.

AU - Solomon, Sunil

AU - Mayer, Kenneth H.

AU - Crowe, Suzanne M.

PY - 2007/12

Y1 - 2007/12

N2 - An inexpensive and technically less-demanding methodology to quantify HIV-1 viral load would be of great value for resource-limited settings, where the nucleic-acid amplification technique (NAAT) is impractical and/or resource-prohibitive. In this study, an HIV-1 reverse-transcriptase enzyme-activity assay (ExaVir Load assay, version 1) was compared with the gold standard RT-PCR assay, Roche HIV-1 Amplicor Monitor, version 1.5. A total of 121 plasma specimens were used for the evaluation. ExaVir Load had a sensitivity of 97 % and a specificity of 71 % in identifying specimens with -1 in the Roche RT-PCR assay as being less than the detection limit of the assay (5500 copies ml-1). The mean difference (95% limits of agreement) between Roche RT-PCR and ExaVir Load was -0.23 (-1.59 to 1.13) log10(copies ml-1) by Bland-Altman analysis. Significant negative correlations were seen between CD4+ T-cell counts and the ExaVir Load assay (r=-0.32, P+ T-cell counts and the Roche RT-PCR (r=-0.38, P

AB - An inexpensive and technically less-demanding methodology to quantify HIV-1 viral load would be of great value for resource-limited settings, where the nucleic-acid amplification technique (NAAT) is impractical and/or resource-prohibitive. In this study, an HIV-1 reverse-transcriptase enzyme-activity assay (ExaVir Load assay, version 1) was compared with the gold standard RT-PCR assay, Roche HIV-1 Amplicor Monitor, version 1.5. A total of 121 plasma specimens were used for the evaluation. ExaVir Load had a sensitivity of 97 % and a specificity of 71 % in identifying specimens with -1 in the Roche RT-PCR assay as being less than the detection limit of the assay (5500 copies ml-1). The mean difference (95% limits of agreement) between Roche RT-PCR and ExaVir Load was -0.23 (-1.59 to 1.13) log10(copies ml-1) by Bland-Altman analysis. Significant negative correlations were seen between CD4+ T-cell counts and the ExaVir Load assay (r=-0.32, P+ T-cell counts and the Roche RT-PCR (r=-0.38, P

UR - http://www.scopus.com/inward/record.url?scp=37249066240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249066240&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.47456-0

DO - 10.1099/jmm.0.47456-0

M3 - Article

C2 - 18033828

AN - SCOPUS:37249066240

VL - 56

SP - 1611

EP - 1614

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 12

ER -